45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
15,140
Insurances with rates
35
CPT / HCPCS codes
12,998
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 764661 | Injection, exagamglogene autotemcel, per treatment | $9,999,999 | $9,999,999 | $6,179,800 | $6,179,800 | 3 |
| 289730 | Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, includ | $6,360,264 | $6,360,264 | $1,489,833 | $1,489,833 | 3 |
| 343369 | Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed ca | $6,330,534 | $6,330,534 | $1,557,271 | $1,557,271 | 3 |
| 189841 | Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, includi | $6,257,460 | $6,257,460 | $1,410,309 | $1,410,309 | 3 |
| 216447 | Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-p | $6,203,445 | $6,203,445 | $1,478,917 | $1,478,917 | 3 |
| 216443 | Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, inclu | $5,740,812 | $5,740,812 | $1,297,043 | $1,297,043 | 3 |
| 689990 | Botulism immune globulin, human, for intravenous use | $353,368 | $353,368 | $60,394 | $68,674 | 2 |
| 327579 | Comprehensive electrophysiologic evaluation with transseptal catheterizations, insertion and reposit | $233,407 | $233,407 | $5,077 | $30,393 | 10 |
| 327577 | Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode c | $218,396 | $218,396 | $2,706 | $39,148 | 10 |
| 327352 | Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode c | $177,369 | $177,369 | $5,077 | $30,393 | 10 |
| 690445 | Injection, loncastuximab tesirine-lpyl, 0.075 mg | $142,461 | $142,461 | $256 | $291 | 2 |
| 681717 | Injection, pegaspargase, per single dose vial | $135,957 | $135,957 | $33,498 | $38,091 | 2 |
| 690365 | Injection, calaspargase pegol-mknl, 10 units | $116,389 | $116,389 | $94.72 | $108 | 2 |
| 690420 | Injection, hemin, 1 mg | $65,285 | $65,285 | $39.83 | $45.29 | 2 |
| 677936 | Injection, carmustine, 100 mg | $62,600 | $62,600 | $469 | $533 | 2 |
| 690680 | Injection, dostarlimab-gxly, 10 mg | $59,176 | $59,176 | $293 | $333 | 2 |
| 690345 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | $53,345 | $53,345 | $63.24 | $71.91 | 2 |
| 327578 | Intracardiac catheter ablation of a discrete mechanism of arrhythmia which is distinct from the prim | $52,794 | $52,794 | $528 | $30,393 | 13 |
| 327580 | Additional linear or focal intracardiac catheter ablation of the left or right atrium for treatment | $52,794 | $52,794 | $291 | $35,281 | 6 |
| 314457 | Intracardiac catheter ablation of atrioventricular node function, atrioventricular conduction for cr | $52,794 | $52,794 | $5,094 | $30,393 | 14 |
| 690393 | Injection, gemtuzumab ozogamicin, 0.1 mg | $52,034 | $52,034 | $285 | $324 | 2 |
| 689895 | Injection, caplacizumab-yhdp, 1 mg | $48,621 | $48,621 | $948 | $1,078 | 2 |
| 689572 | Injection, pertuzumab, 1 mg | $47,770 | $47,770 | $19.78 | $22.49 | 2 |
| 690188 | Injection, tenecteplase, 1 mg | $46,608 | $46,608 | $195 | $222 | 2 |
| 314402 | Intraventricular and/or intra-atrial mapping of tachycardia site(s) with catheter manipulation to re | $46,357 | $46,357 | $126 | $30,393 | 11 |
| 677324 | Injection, aldesleukin, per single use vial | $40,924 | $40,924 | $7,022 | $7,984 | 2 |
| 534390 | Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, re | $39,385 | $39,385 | $4,913 | $7,602 | 32 |
| 690397 | Injection, atezolizumab, 10 mg | $39,234 | $39,234 | $106 | $121 | 2 |
| 690716 | Injection, tisotumab vedotin-tftv, 1 mg | $35,725 | $35,725 | $217 | $247 | 2 |
| 314411 | Intracardiac electrophysiologic 3-dimensional mapping (List separately in addition to code for prima | $35,468 | $35,468 | $369 | $30,393 | 11 |
| 679705 | Injection, digoxin immune fab (ovine), per vial | $34,570 | $34,570 | $5,924 | $6,736 | 2 |
| 682397 | Injection, melphalan hydrochloride, not otherwise specified, 50 mg | $33,481 | $33,481 | $193 | $219 | 2 |
| 690681 | Injection, mirvetuximab soravtansine-gynx, 1 mg | $33,268 | $33,268 | $82.92 | $94.29 | 2 |
| 689145 | Injection, calcitonin salmon, up to 400 units | $33,233 | $33,233 | $1,329 | $1,511 | 2 |
| 314404 | Intra-atrial pacing | $31,142 | $31,142 | $61.94 | $30,393 | 13 |
| 314408 | Intraventricular pacing | $31,142 | $31,142 | $74.16 | $30,393 | 13 |
| 314397 | Intra-atrial recording | $31,142 | $31,142 | $50.64 | $30,393 | 13 |
| 314437 | Programmed stimulation and pacing after intravenous drug infusion (List separately in addition to co | $31,142 | $31,142 | $398 | $30,393 | 11 |
| 314416 | Induction of arrhythmia by electrical pacing | $30,923 | $30,923 | $188 | $30,393 | 13 |
| 534374 | Microprocessor control unit for use with electric ventricular assist device, replacement only | $30,390 | $30,390 | $17,090 | $26,445 | 32 |
| 772348 | Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg | $30,118 | $30,118 | $23.98 | $27.27 | 2 |
| 103507 | Infectious agent genotype analysis by nucleic acid (DNA or RNA); cytomegalovirus | $29,302 | $29,302 | $1,030 | $1,030 | 4 |
| 314435 | Comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electr | $27,965 | $27,965 | $1,940 | $30,393 | 11 |
| 314431 | Comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electr | $27,965 | $27,965 | $426 | $30,393 | 13 |
| 314433 | Comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electr | $27,965 | $27,965 | $3,026 | $30,393 | 11 |
| 314426 | Comprehensive electrophysiologic evaluation with right atrial pacing and recording, right ventricula | $27,965 | $27,965 | $377 | $30,393 | 13 |
| 690443 | Injection, artesunate, 1 mg | $26,975 | $26,975 | $57.26 | $65.11 | 2 |
| 332615 | Radiation treatment delivery, stereotactic radiosurgery (SRS), complete course of treatment of crani | $26,935 | $26,935 | $862 | $33,163 | 16 |
| 314439 | Electrophysiologic follow-up study with pacing and recording to test effectiveness of therapy, inclu | $24,929 | $24,929 | $92.97 | $30,393 | 13 |
| 683649 | Respiratory syncytial virus, monoclonal antibody, recombinant, for intramuscular use, 50 mg, each | $24,393 | $24,393 | $2,529 | $2,875 | 2 |
Showing top 50 of 15,140 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.